{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:46:46Z","timestamp":1793879206700,"version":"4.7.0"},"reference-count":19,"publisher":"American Medical Association (AMA)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,6,2]]},"DOI":"10.1001\/jama.2020.6348","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T11:34:43Z","timestamp":1591097683000},"page":"2160","source":"Crossref","is-referenced-by-count":252,"title":["Effect of C-Reactive Protein\u2013Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia"],"prefix":"10.1001","volume":"323","author":[{"given":"Elodie","family":"von Dach","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland"},{"name":"Faculty of Medicine, Clinical Research Center, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner C.","family":"Albrich","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Brunel","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, University Hospital, University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Prendki","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Internal Medicine of the Aged, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Cuvelier","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Internal Medicine of the Aged, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Flury","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e8le","family":"Gayet-Ageron","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Clinical Research Center, Geneva University Hospitals, Geneva, Switzerland"},{"name":"Division of Clinical Epidemiology, Department of Health and Community Medicine, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Huttner","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Kohler","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Lemmenmeier","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawna","family":"McCallin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rossel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Harbarth","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Bochud","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, University Hospital, University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Huttner","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"joi200041r1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-14-13","article-title":"A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance.","volume":"14","author":"Bell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"joi200041r2","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2217\/fmb-2018-0157","article-title":"Vulnerability of long-term care facility residents to Clostridium difficile infection due to microbiome disruptions.","volume":"13","author":"Fuchs","year":"2018","journal-title":"Future Microbiol"},{"issue":"6","key":"joi200041r3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/1469-0691.12144","article-title":"Incidence of bloodstream infection: a review of population-based studies.","volume":"19","author":"Laupland","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"joi200041r4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial.","volume":"69","author":"Yahav","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"joi200041r5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/cid\/cix767","article-title":"Comparing the outcomes of adults with Enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score-matched cohort.","volume":"66","author":"Chotiprasitsakul","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"7","key":"joi200041r6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.","volume":"16","author":"de Jong","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"9713","key":"joi200041r7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"},{"issue":"10","key":"joi200041r8","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s00134-015-3978-8","article-title":"Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.","volume":"41","author":"Albrich","year":"2015","journal-title":"Intensive Care Med"},{"issue":"1","key":"joi200041r9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.diagmicrobio.2014.03.029","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis.","volume":"80","author":"Lin","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"joi200041r10","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1097\/CCM.0b013e31828e969f","article-title":"Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial.","volume":"41","author":"Oliveira","year":"2013","journal-title":"Crit Care Med"},{"issue":"7","key":"joi200041r11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017996","article-title":"PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in gram-negative bacteraemia.","volume":"7","author":"Huttner","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"joi200041r13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.cmi.2015.10.034","article-title":"Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals.","volume":"22","author":"Fitzpatrick","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"joi200041r14","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1097\/CCM.0000000000001730","article-title":"A framework for the development and interpretation of different sepsis definitions and clinical criteria.","volume":"44","author":"Angus","year":"2016","journal-title":"Crit Care Med"},{"issue":"11","key":"joi200041r15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/BF02000400","article-title":"Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality.","volume":"12","author":"Pittet","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"joi200041r16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/jac\/dkh356","article-title":"Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.","volume":"54","author":"Tellier","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"joi200041r17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/cid\/cis688","article-title":"White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens.","volume":"55","author":"Infectious Diseases Society of America","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9840","key":"joi200041r18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0140-6736(12)60608-4","article-title":"Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial.","volume":"380","author":"Sandberg","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"joi200041r19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2018-000391","article-title":"Point-of-care C-reactive protein testing to optimise antibiotic use in a primary care urgent care centre setting.","volume":"7","author":"Ward","year":"2018","journal-title":"BMJ Open Qual"},{"key":"joi200041r12","unstructured":"US Food and Drug Administration. Guidance for Industry: Collection of Race and Ethnicity Data in Clinical Trials. US Food and Drug Administration; 2016."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2766635\/jama_von_dach_2020_oi_200041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T11:34:49Z","timestamp":1591097689000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2766635"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":19,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2020,6,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.6348","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,2]]}}}